Fabio Valguarnera

Responders and super-responders to atogepant after 24 weeks of treatment in migraine: real-world evidence from the GIANT-2 study

Piero Barbanti, Gabriella Egeo, Alberto Doretti, Francesca Pistoia et autres

it, us, br (code pays fourni par la source)

Erratum to: Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study

Gianni Allais, Gennaro Bussone, V. Tullo, Pietro Cortelli et autres

it (code pays fourni par la source)

Early (≤1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study

Gianni Allais, Gennaro Bussone, V. Tullo, Pietro Cortelli et autres

it (code pays fourni par la source)

EHMTI-0052. Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura

Gianni Allais, V. Tullo, Pietro Cortelli, Piero Barbanti et autres

it (code pays fourni par la source)

Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial

Gianni Allais, Gennaro Bussone, V. Tullo, Pietro Cortelli et autres

it (code pays fourni par la source)

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura

Gianni Allais, V. Tullo, Pietro Cortelli, Piero Barbanti et autres

it (code pays fourni par la source)

Efficacy of early vs. late use of frovatriptan combined with dexketoprofen vs. frovatriptan alone in the acute treatment of migraine attacks with or without aura Gianni AllaisVincenzo TulloPietro CortelliPiero BarbantiFabio Valguarnera • Giuliano SetteFlorindo D'OnofrioMarcella CuroneDario ZavaDeborha Pezzola • Giorgio ReggiardoStefano OmboniFabio FredianiGennaro BussoneChiara Benedetto

Gianni Allais, Chiara Benedetto, V. Tullo, M. Curone et autres

Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: A randomized study

V. Tullo, Fabio Valguarnera, Piero Barbanti, Pietro Cortelli et autres

it (code pays fourni par la source)

Almotriptan 12.5 mg in menstrually related migraine: A randomized, double-blind, placebo-controlled study

Gianni Allais, Gennaro Bussone, Giovanni D’Andrea, F. Moschiano et autres

it, us, gb, es (code pays fourni par la source)

Evolution of migraine-associated symptoms in menstrually related migraine following symptomatic treatment with almotriptan

Gianni Allais, Giancarlo Acuto, Chiara Benedetto, Giovanni D’Andrea et autres

it, es, de, us (code pays fourni par la source)

The efficacy of withdrawal therapy in subjects with chronic daily headache and medication overuse following prophylaxis with topiramate and amitriptyline

Fabio Valguarnera, Paolo Tanganelli

it (code pays fourni par la source)

Underdiagnosis and Undertreatment of Migraine in Italy: A Survey of Patients Attending for The First Time 10 Headache Centres

Sabina Cevoli, Domenico D’Amico, Paolo Martelletti, Fabio Valguarnera et autres

it (code pays fourni par la source)